Back to search
IgE Mediated Peanut Allergy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which IgE Mediated Peanut Allergy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which IgE Mediated Peanut Allergy trials you may qualify forThis study is researching an experimental drug called linvoseltamab combined with another drug called dupilumab. The study is looking at patients who have sever…
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy: This is a Phase 2b randomized, double-blind, placebo-controlled clinical…
Food allergy affects 1 in 30 children, and is the commonest trigger for life-threatening reactions (anaphylaxis) in this age group. It is a major public health…
The purpose of this study is to evaluate the pharmacodynamics, safety, tolerability, pharmacokinetics, and immunogenicity of cizutamig in IgE Mediated Diseases.
The PEPITES study evaluates the efficacy and safety of Viaskin Peanut 250 µg peanut protein to induce desensitization to peanut in peanut-allergic children 4 th…
The aim is to analyse the results of per oral immunotherapy treatment in severe milk, peanut or egg allergy in adults. This is the second part of the oral immun…